CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | Invus Public Equities, L.P. 10% owner | Purchase | +31,557 | $6.43 | $203K | 9,059,507 |
| 2023-04-06 | Brudnick Richard Director | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2023-02-13 | Myles Edward H COO & CFO | Grant or award | +63,750 | 210,929 | ||
| 2023-02-13 | Myles Edward H COO & CFO | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-02-13 | Parlavecchio Caryn CHRO | Grant or award | +46,875 | 122,590 | ||
| 2023-02-13 | Parlavecchio Caryn CHRO | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2023-02-13 | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | Grant or award | +150,000 | 150,000 | ||
| 2023-02-13 | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-02-13 | Ho Junlin GENERAL COUNSEL | Grant or award | +46,875 | 162,937 | ||
| 2023-02-13 | Ho Junlin GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2023-01-17 | Myles Edward H COO & CFO | Shares withheld for taxes | −7,043 | $11.29 | $80K | 147,179 |
| 2023-01-17 | Parlavecchio Caryn CHRO | Shares withheld for taxes | −2,934 | $11.28 | $33K | 75,715 |
| 2023-01-17 | Ho Junlin GENERAL COUNSEL | Shares withheld for taxes | −4,529 | $11.29 | $51K | 116,062 |
| 2023-01-09 | Invus Public Equities, L.P. 10% owner | Sale | −1,094 | $9.48 | $10K | 9,027,950 |
| 2023-01-05 | Invus Public Equities, L.P. 10% owner | Purchase | +48,774 | $9.33 | $455K | 9,029,044 |
| 2022-11-14 | Marantz Jing L. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-10-25 | Invus Public Equities, L.P. 10% owner | Purchase | +130,265 | $8.04 | $1.0M | 8,980,270 |
| 2022-10-04 | Invus Public Equities, L.P. 10% owner | Purchase | +66,000 | $7.89 | $521K | 8,850,005 |
| 2022-10-03 | Invus Public Equities, L.P. 10% owner | Purchase | +33,971 | $7.03 | $239K | 8,784,005 |
| 2022-09-20 | Backstrom Jay T. CEO-Elect | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 |
Page 20 of 22 · 422 trades